More breast cancer patients could benefit from treatments currently used only for patients with a faulty BRCA1 or BRCA2 gene, an international research collaboration has shown.
14 March 2017Search UQ News
More breast cancer patients could benefit from treatments currently used only for patients with a faulty BRCA1 or BRCA2 gene, an international research collaboration has shown.
14 March 2017
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B